Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity
This study has been completed.
Study NCT00689208   Information provided by AstraZeneca

First Received on May 30, 2008.   Last Updated on March 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Insulin Resistance
More general conditions related to this trial
Glucose Metabolism Disorders
Hyperinsulinism
Metabolic Diseases
Interventions listed in this trial
Atropine
Physostigmine
Placebo Sodium
More general drug interventions related to this trial
Adjuvants, Anesthesia
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Cholinesterase Inhibitors
Enzyme Inhibitors
Miotics
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Mydriatics
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services